Subject
Pharmacology,Immunology,Immunology and Allergy
Reference14 articles.
1. “COVID-19 Vaccines for Moderately or Severely Immunocompromised People | CDC,” National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Fhcp%2Fimmunocompromised-patients.html (accessed Apr. 21, 2022).
2. Haematological abnormalities and risk of covid-19 infection in adult patients attending primary healthcare settings;Hamed;Hematol. Rep.,2020
3. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies;Goldman;J. Immunother. Cancer,2021
4. A. Rahman, R. Niloofa, U. Jayarajah, S. de Mel, V. Abeysuriya, and S. L. Seneviratne, “Hematological abnormalities in COVID-19: A narrative review,” American Journal of Tropical Medicine and Hygiene, vol. 104, no. 4. American Society of Tropical Medicine and Hygiene, pp. 1188–1201, Apr. 01, 2021. 10.4269/ajtmh.20-1536.
5. Role of hematological parameters in COVID-19 patients in the emergency room;Usul;Biomark. Med.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献